These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 28708853)
1. Selective serotonin reuptake inhibitors and venlafaxine in pregnancy: Changes in drug disposition. Westin AA; Brekke M; Molden E; Skogvoll E; Spigset O PLoS One; 2017; 12(7):e0181082. PubMed ID: 28708853 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients. Hermann M; Waade RB; Molden E Ther Drug Monit; 2015 Aug; 37(4):546-9. PubMed ID: 25565671 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Nemeroff CB; Entsuah R; Benattia I; Demitrack M; Sloan DM; Thase ME Biol Psychiatry; 2008 Feb; 63(4):424-34. PubMed ID: 17888885 [TBL] [Abstract][Full Text] [Related]
4. Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database. Reis M; Aamo T; Spigset O; Ahlner J Ther Drug Monit; 2009 Feb; 31(1):42-56. PubMed ID: 19077925 [TBL] [Abstract][Full Text] [Related]
5. Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism. Preskorn SH Clin Pharmacokinet; 1997; 32 Suppl 1():1-21. PubMed ID: 9068931 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis. Kennedy SH; Andersen HF; Lam RW J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428 [TBL] [Abstract][Full Text] [Related]
7. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions. Mandrioli R; Mercolini L; Saracino MA; Raggi MA Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078 [TBL] [Abstract][Full Text] [Related]
9. Postpartum Bleeding in Pregnant Women Receiving SSRIs/SNRIs: New Insights From a Descriptive Observational Study and an Analysis of Data from the FAERS Database. Perrotta C; Giordano F; Colombo A; Carnovale C; Castiglioni M; Di Bernardo I; Giorgetti F; Pileri P; Clementi E; Viganò C Clin Ther; 2019 Sep; 41(9):1755-1766. PubMed ID: 31371035 [TBL] [Abstract][Full Text] [Related]
10. Serum and Saliva Concentrations of Venlafaxine, O-Desmethylvenlafaxine, Quetiapine, and Citalopram in Psychiatric Patients. Ebert K; Maurice E; Lukačin R; Fleischhaker C; Schulz E; Ebert D; Clement HW Ther Drug Monit; 2018 Jun; 40(3):351-355. PubMed ID: 29746434 [TBL] [Abstract][Full Text] [Related]
11. The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis. Lam D; Gorman DA; Patten S; Pringsheim T Paediatr Drugs; 2013 Aug; 15(4):319-27. PubMed ID: 23529865 [TBL] [Abstract][Full Text] [Related]
12. The effect of venlafaxine compared with other antidepressants and placebo in the treatment of major depression: a meta-analysis. Bauer M; Tharmanathan P; Volz HP; Moeller HJ; Freemantle N Eur Arch Psychiatry Clin Neurosci; 2009 Apr; 259(3):172-85. PubMed ID: 19165525 [TBL] [Abstract][Full Text] [Related]
13. Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Hayasaka Y; Purgato M; Magni LR; Ogawa Y; Takeshima N; Cipriani A; Barbui C; Leucht S; Furukawa TA J Affect Disord; 2015 Jul; 180():179-84. PubMed ID: 25911132 [TBL] [Abstract][Full Text] [Related]
15. Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2. Ball SE; Ahern D; Scatina J; Kao J Br J Clin Pharmacol; 1997 Jun; 43(6):619-26. PubMed ID: 9205822 [TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression. Stahl SM; Entsuah R; Rudolph RL Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062 [TBL] [Abstract][Full Text] [Related]
17. Vortioxetine for major depressive disorder: An indirect comparison with duloxetine, escitalopram, levomilnacipran, sertraline, venlafaxine, and vilazodone, using number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L J Affect Disord; 2016 May; 196():225-33. PubMed ID: 26938965 [TBL] [Abstract][Full Text] [Related]
18. Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation. Bondolfi G; Chautems C; Rochat B; Bertschy G; Baumann P Psychopharmacology (Berl); 1996 Dec; 128(4):421-5. PubMed ID: 8986013 [TBL] [Abstract][Full Text] [Related]
19. Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine. Luong TT; Powers CN; Reinhardt BJ; Weina PJ Curr Res Pharmacol Drug Discov; 2022; 3():100112. PubMed ID: 35756846 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of venlafaxine extended release and conventional antidepressants in elderly patients with depressive disorder]. Agüera-Ortiz L; Ramos Garcia I Actas Esp Psiquiatr; 2006; 34(3):153-61. PubMed ID: 16736388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]